Stay updated on AbbVie Press Releases

Sign up to get notified when there's something new on the AbbVie Press Releases page.
Latest website image capture
Clouds background image

Latest updates to the AbbVie Press Releases page

  1. Check
    2 days ago
    Change Detected
    Summary
    Added a new press release item about the FDA accepting Allergan Aesthetics' supplemental Biologics License Application for BOTOX Cosmetic for Masseter Muscle Prominence. Removed several older major announcements, including the European Commission approval for RINVOQ in Alopecia Areata and related updates.
    Difference
    3%
    Check dated 2026-08-08T15:43:42.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The News Center feed gained new items such as quarterly financial results, a regulatory approval announcement, and an earnings call link, while older social posts and notices were removed to clean up the feed.
    Difference
    12%
    Check dated 2026-08-01T12:04:58.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    A new AbbVie News Center item was added regarding clarification on the EPCORE DLBCL-1 trial; at the same time, several older press releases and social posts were removed or trimmed as part of a content refresh.
    Difference
    8%
    Check dated 2026-07-25T07:43:02.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    The News Center page was updated with two new items: Allergan Aesthetics’ approval for Boey in Europe and SkinMedica’s continued investment in regenerative science. At the same time, older press releases about MAVIRET and SKYRIZI approvals were removed to refresh the current news feed.
    Difference
    5%
    Check dated 2026-07-18T02:13:51.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    A new press release announces European Commission approval of TEPKINLY (epcoritamab) in combination with lenalidomide and rituximab for relapsed/refractory follicular lymphoma, updating the News Center with a regulatory milestone. Older posts such as the CHMP opinion for Upadacitinib in non-segmental vitiligo and the AbbVie–Apogee Therapeutics acquisition were removed from the listing, refreshing the feed with more recent news.
    Difference
    8%
    Check dated 2026-07-10T22:36:43.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    Adds three June 29, 2026 press releases about positive Phase 3 results and CHMP opinions to the News Center. Simultaneously, several older news items are removed to refresh the feed.
    Difference
    11%
    Check dated 2026-07-03T21:50:11.000Z thumbnail image

Stay in the know with updates to AbbVie Press Releases

Enter your email address, and we'll notify you when there's something new on the AbbVie Press Releases page.